You have no items in your shopping cart.
Product Description
Description
VSL#3® is a high-potency medical food probiotic consisting of live freeze-dried lactic acid bacteria. Each dose contains 450 billion live lactic acid bacteria per packet in defined ratios of lyophilized Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus bulgaricus, Streptococcus thermophilus.
Intended Use
VSL#3® is intended to be used in the dietary management of medically diagnosed ulcerative colitis, Irritable Bowel Syndrome, or an ileal pouch.
Physiology
VSL#3® provides specifically modified nutritional support for the management of medically diagnosed ulcerative colitis (UC), Irritable Bowel Syndrome, or an ileal pouch by delivering a high concentration of several strains of live bacteria in a formulation that survives gastric fluid, bile, and pancreatic secretions, and colonizes the gastrointestinal tract. Studies have demonstrated that the gut microflora modulate intestinal inflammation, reduce colonic permeability, and enhance barrier function. Patients with pouchitis who received VSL#3® were found to have increased concentrations of the anti-inflammatory cytokine IL-10 and reduction of the pro-inflammatory cytokines IL-1α, interferon-γ, and tumor necrosis factor- α, as well as inducible nitric oxide synthase and matrix metalloproteinase activity to concentrations similar to those found in non-inflamed pouches.
Product Specifications
VSL#3® comes in a powder that is intended to be mixed with at least 4 ounces of cold water and consumed.
VSL#3® is available as an unflavored powder that is intended to be mixed with yogurt, ice-cream, apple sauce or any other cold food and consumed. Ingredients – 450 billion lactic acid bacteria, cornstarch.
Storage – Packets should be refrigerated (39-46° F). The product may be stored at room temperature for up to a week without adversely affecting potency.
Shelf life - 2 years from manufacturing date when stored properly (39-46° F).
Drug Interactions
Avoid taking together with antibiotics. Antibiotics may inactivate the live bacteria in VSL#3®.
Side Effects
None known
VSL#3® is one of the few probiotic preparations supported by Level One (double-blind, placebo controlled) scientific data.
VSL#3® has been the subject of extensive clinical research in the dietary management of ulcerative colitis, irritable bowel syndrome, an ileal pouch, and several other clinical conditions.
Who Uses VSL#3®?
The probiotic medical food for the dietary management of Ulcerative Colitis, Irritable Bowel Syndrome (IBS), or an Ileal Pouch
The human gastrointestinal (GI) system is populated by thousands of billions of beneficial bacteria that act as a protective barrier throughout the GI system. These bacteria perform a variety of important biochemical functions from enhancing the protective intestinal barrier to modulating intestinal inflammation and reducing colonic permeability.
Under some conditions the number of pathogenic ("bad") bacteria in a person’s intestines can begin to outnumber the good bacteria. Numerous studies have implicated the overgrowth of pathogenic bacteria in certain intestinal disorders. Studies have shown that patients with ulcerative colitis (UC), irritable bowel syndrome (IBS), or an ileal pouch tend to have a decreased concentration of beneficial bacteria. This deficiency could lead to more flare-ups and issues with diarrhea, frequency, and urgency.
VSL#3® is the only medical food that can restore beneficial intestinal bacteria in UC, IBS and pouch patients with optimal quantities and types of beneficial bacteria.
Ulcerative Colitis Patients – Several published studies have showed that daily ingestion of VSL#3® can aid in the dietary management of ulcerative colitis (UC).
Patients with irritable bowel syndrome – Patients involved in two double blind placebo-controlled trials reported satisfactory relief of gas and bloating associated with IBS.
Patients with an Ileal Pouch – VSL#3® has been recognized by the American College of Gastroenterology Practice Parameter as a tool for the dietary management of pouchitis. Three double-blind, placebo controlled trials have shown that VSL#3® is important for the dietary management of pouchitis.
!!!! Keep your product refrigerated. Shipment is done with suitable box. !!!!
VSL#3® is a high-potency medical food probiotic consisting of live freeze-dried lactic acid bacteria. Each dose contains 450 billion live lactic acid bacteria per packet in defined ratios of lyophilized Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus bulgaricus, Streptococcus thermophilus.
Intended Use
VSL#3® is intended to be used in the dietary management of medically diagnosed ulcerative colitis, Irritable Bowel Syndrome, or an ileal pouch.
Physiology
VSL#3® provides specifically modified nutritional support for the management of medically diagnosed ulcerative colitis (UC), Irritable Bowel Syndrome, or an ileal pouch by delivering a high concentration of several strains of live bacteria in a formulation that survives gastric fluid, bile, and pancreatic secretions, and colonizes the gastrointestinal tract. Studies have demonstrated that the gut microflora modulate intestinal inflammation, reduce colonic permeability, and enhance barrier function. Patients with pouchitis who received VSL#3® were found to have increased concentrations of the anti-inflammatory cytokine IL-10 and reduction of the pro-inflammatory cytokines IL-1α, interferon-γ, and tumor necrosis factor- α, as well as inducible nitric oxide synthase and matrix metalloproteinase activity to concentrations similar to those found in non-inflamed pouches.
Product Specifications
VSL#3® comes in a powder that is intended to be mixed with at least 4 ounces of cold water and consumed.
VSL#3® is available as an unflavored powder that is intended to be mixed with yogurt, ice-cream, apple sauce or any other cold food and consumed. Ingredients – 450 billion lactic acid bacteria, cornstarch.
Storage – Packets should be refrigerated (39-46° F). The product may be stored at room temperature for up to a week without adversely affecting potency.
Shelf life - 2 years from manufacturing date when stored properly (39-46° F).
Drug Interactions
Avoid taking together with antibiotics. Antibiotics may inactivate the live bacteria in VSL#3®.
Side Effects
None known
VSL#3® is one of the few probiotic preparations supported by Level One (double-blind, placebo controlled) scientific data.
VSL#3® has been the subject of extensive clinical research in the dietary management of ulcerative colitis, irritable bowel syndrome, an ileal pouch, and several other clinical conditions.
Who Uses VSL#3®?
The probiotic medical food for the dietary management of Ulcerative Colitis, Irritable Bowel Syndrome (IBS), or an Ileal Pouch
The human gastrointestinal (GI) system is populated by thousands of billions of beneficial bacteria that act as a protective barrier throughout the GI system. These bacteria perform a variety of important biochemical functions from enhancing the protective intestinal barrier to modulating intestinal inflammation and reducing colonic permeability.
Under some conditions the number of pathogenic ("bad") bacteria in a person’s intestines can begin to outnumber the good bacteria. Numerous studies have implicated the overgrowth of pathogenic bacteria in certain intestinal disorders. Studies have shown that patients with ulcerative colitis (UC), irritable bowel syndrome (IBS), or an ileal pouch tend to have a decreased concentration of beneficial bacteria. This deficiency could lead to more flare-ups and issues with diarrhea, frequency, and urgency.
VSL#3® is the only medical food that can restore beneficial intestinal bacteria in UC, IBS and pouch patients with optimal quantities and types of beneficial bacteria.
Ulcerative Colitis Patients – Several published studies have showed that daily ingestion of VSL#3® can aid in the dietary management of ulcerative colitis (UC).
Patients with irritable bowel syndrome – Patients involved in two double blind placebo-controlled trials reported satisfactory relief of gas and bloating associated with IBS.
Patients with an Ileal Pouch – VSL#3® has been recognized by the American College of Gastroenterology Practice Parameter as a tool for the dietary management of pouchitis. Three double-blind, placebo controlled trials have shown that VSL#3® is important for the dietary management of pouchitis.
!!!! Keep your product refrigerated. Shipment is done with suitable box. !!!!
Additional Information
| Handling Fee | € 105.10 |
Product Tags
Add Your Tags:
Use spaces to separate tags. Use single quotes (') for phrases.
